Event : Why is Liver Injury (DILI) the Most Frequent Reason for a Drug Being Pulled from the Market http://www.rsc.org/events/detail/10293/Why%20is%20Liver%20Injury%20(DILI)%20the%20Most%20Frequent%20Reason%20for%20a%20Drug%20Being%20Pulled%20from%20the%20Market This is a feed for event : Why is Liver Injury (DILI) the Most Frequent Reason for a Drug Being Pulled from the Market Thu, 11 Sep 2014 13:13:13 +0100 10293 10293 http://www.rsc.org/events/detail/10293/Why%20is%20Liver%20Injury%20(DILI)%20the%20Most%20Frequent%20Reason%20for%20a%20Drug%20Being%20Pulled%20from%20the%20Market Why is Liver Injury (DILI) the Most Frequent Reason for a Drug Being Pulled from the Market Event dates: 5 February 2014<br/>Event summary: Determining the relationship between the study drug and an AE requires a practiced power of observation & great care (good medical judgment). Determining if an IMP is subject to liver injury separat<br/>Event Venue: Online Webinar, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00